Immunosuppressive Functions of M2 Macrophages Derived from iPSCs of Patients with ALS and Healthy Controls
Summary: Amyotrophic lateral sclerosis (ALS) is a disorder with immune alterations that augment disease severity. M2 macrophages benefit diabetic and nephrotic mice by suppressing the pro-inflammatory state. However, neither have M2 cells been investigated in ALS nor have human induced pluripotent s...
Main Authors: | Weihua Zhao, David R. Beers, Jason R. Thonhoff, Aaron D. Thome, Alireza Faridar, Jinghong Wang, Shixiang Wen, Loren Ornelas, Dhruv Sareen, Helen S. Goodridge, Clive N. Svendsen, Stanley H. Appel |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-06-01
|
Series: | iScience |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2589004220303771 |
Similar Items
-
Serum programmed cell death proteins in amyotrophic lateral sclerosis
by: David R. Beers, et al.
Published: (2021-03-01) -
Functional alterations of myeloid cells during the course of Alzheimer’s disease
by: Aaron D. Thome, et al.
Published: (2018-11-01) -
Ex vivo expansion of dysfunctional regulatory T lymphocytes restores suppressive function in Parkinson’s disease
by: Aaron D. Thome, et al.
Published: (2021-05-01) -
iPSCs are safe!
by: Hualong Yan, et al.
Published: (2017-05-01) -
iPSCs in Modeling and Therapy of Osteoarthritis
by: Maria Csobonyeiova, et al.
Published: (2021-02-01)